National Health Investors (NYSE:NHI) Releases FY24 Earnings Guidance

National Health Investors (NYSE:NHI) issued an update on its FY24 earnings guidance on Tuesday morning. The company provided earnings per share guidance of $4.37-4-43 for the period, compared to the consensus earnings per share estimate of $4.35.

Wall Street Analyst Weigh In

A number of equities research analysts have recently commented on NHI shares. Wells Fargo & Company upgraded National Health Investors from an equal weight rating to an overweight rating and raised their target price for the company from $55.00 to $63.00 in a research report on Monday, February 26th. BMO Capital Markets raised National Health Investors from a market perform rating to an outperform rating and set a $67.00 target price for the company in a research note on Tuesday, March 12th. Deutsche Bank Aktiengesellschaft began coverage on shares of National Health Investors in a research note on Tuesday, January 30th. They issued a buy rating and a $69.00 price target on the stock. Truist Financial boosted their price target on shares of National Health Investors from $55.00 to $58.00 and gave the stock a hold rating in a report on Thursday, April 4th. Finally, Wedbush increased their price objective on shares of National Health Investors from $64.00 to $66.00 and gave the company an outperform rating in a report on Monday, March 18th. Five analysts have rated the stock with a hold rating and four have assigned a buy rating to the stock. Based on data from MarketBeat.com, the stock has a consensus rating of Hold and an average target price of $60.50.

National Health Investors Price Performance

Shares of National Health Investors stock traded down $0.01 during trading hours on Wednesday, reaching $65.64. 187,871 shares of the company’s stock were exchanged, compared to its average volume of 171,536. The business has a fifty day moving average of $60.81 and a two-hundred day moving average of $56.48. The company has a market capitalization of $2.85 billion, a P/E ratio of 20.97 and a beta of 0.95. The company has a quick ratio of 10.27, a current ratio of 10.27 and a debt-to-equity ratio of 0.90. National Health Investors has a 1 year low of $48.51 and a 1 year high of $66.10.

National Health Investors Announces Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, August 2nd. Shareholders of record on Friday, June 28th will be issued a $0.90 dividend. The ex-dividend date of this dividend is Friday, June 28th. This represents a $3.60 dividend on an annualized basis and a yield of 5.48%. National Health Investors’s payout ratio is 115.02%.

Insiders Place Their Bets

In related news, Director Charlotte A. Swafford acquired 10,000 shares of the stock in a transaction on Tuesday, February 27th. The shares were bought at an average price of $58.69 per share, with a total value of $586,900.00. Following the completion of the purchase, the director now owns 110,185 shares of the company’s stock, valued at approximately $6,466,757.65. The acquisition was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website. Corporate insiders own 8.21% of the company’s stock.

National Health Investors Company Profile

Incorporated in 1991, National Health Investors, Inc (NYSE:NHI) is a real estate investment trust specializing in sale, leasebacks, joint-ventures, senior housing operating partnerships, and mortgage and mezzanine financing of need-driven and discretionary senior housing and medical investments. NHI's portfolio consists of independent living, assisted living and memory care communities, entrance-fee retirement communities, skilled nursing facilities, and specialty hospitals.